Literature DB >> 17029598

Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets.

Othman Ghribi1, Mikhail Y Golovko, Brian Larsen, Matthew Schrag, Eric J Murphy.   

Abstract

Hypercholesterolemia is a potential trigger of Alzheimer's disease, and is thought to increase brain levels of beta-amyloid (Abeta) and iron. However, animal models to address the mechanisms by which Abeta and iron accumulation may cause neuronal damage are poorly defined. To address this question, we fed adult rabbits a 1% cholesterol-enriched diet for 7 months. This diet was associated with increased regional deposition of both iron and Abeta peptide in the brain. Iron preferentially accumulated around Abeta plaques in the adjacent cortex, but was not found in the hippocampus. Co-localization of iron and Abeta was accompanied by apoptosis, DNA damage, blood-brain barrier (BBB) disruption, as well as dysregulation in the level of the iron-regulatory proteins, ferritin and heme-oxygenase-1. We further demonstrate that the cholesterol diet-induced apoptosis is mediated by the activation of the endoplasmic reticulum stress pathway, involving the down-regulation of the endoplasmic reticulum chaperones, calreticulin, grp78 and grp94, and the activation of the growth and arrest DNA damage protein, gadd153. Our results suggest that BBB damage and disturbances in iron metabolism may render the cortex more vulnerable than the hippocampus to the cholesterol-induced cellular stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029598     DOI: 10.1111/j.1471-4159.2006.04079.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  60 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Metals, oxidative stress and neurodegenerative disorders.

Authors:  Klaudia Jomova; Dagmar Vondrakova; Michael Lawson; Marian Valko
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 3.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

4.  Human brain myelination and amyloid beta deposition in Alzheimer's disease.

Authors:  George Bartzokis; Po H Lu; Jim Mintz
Journal:  Alzheimers Dement       Date:  2007-04       Impact factor: 21.566

Review 5.  Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?

Authors:  Juan F Codocedo; Juvenal A Ríos; Juan A Godoy; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

Review 6.  Regulation of cerebral cholesterol metabolism in Alzheimer disease.

Authors:  Allison B Reiss; Iryna Voloshyna
Journal:  J Investig Med       Date:  2012-03       Impact factor: 2.895

Review 7.  Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Exp Gerontol       Date:  2014-09-28       Impact factor: 4.032

8.  Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat.

Authors:  Ann-Charlotte Granholm; Heather A Bimonte-Nelson; Alfred B Moore; Matthew E Nelson; Linnea R Freeman; Kumar Sambamurti
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

9.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

10.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.